The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

October 19, 2020 • By Richard L. Allman, MD, MS, FACP, FACR

  • Tweet
  • Email
Print-Friendly Version / Save PDF
anttoniart / shutterstock.com

anttoniart / shutterstock.com

Our hospitals have had their finest hour in the care of acutely ill inpatients during the COVID-19 pandemic, including dealing with allocation decisions fairly and transparently, maximizing good outcomes and remaining cognizant of the enduring ethics of healthcare. The honorable traditions of self-effacing conduct and acceptance of some level of personal risk by healthcare professionals have justifiably been lauded within the professions and in the broader society. We have endeavored to meet the needs of patients competently, efficiently and without consideration of disability, ethnicity, citizenship status, social or economic position, or other judgments of a patient’s social worth.

You Might Also Like
  • With Apps & Remote Medicine, Japan Offers Glimpse of Doctor Visits in Post-COVID-19 Era
  • Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD
  • Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19
Explore This Issue
October 2020

Where we are, and will be, in the care of patients in an ambulatory setting in the post-COVID-19 era remains unresolved. The new normal is telemedicine. The reasons are under­standable, including the need to protect our patients from COVID-19 exposure, to protect our staffs and ourselves, to have safe waiting areas, to have adequate personal protective equipment and to accommodate simple matters, such as cleaning exam­ination rooms.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For the foreseeable future, live, face-to-face visits with patients will be the exception. This will be aggravated by inevitable time and space constraints in clinic areas, all of which will affect throughput.

Telemedicine has provided some revenue flow for healthcare networks that have been severely affected by the suspension of profitable clinical services during the pandemic. In rheumatology, televisits are transactional; we get some idea of how a patient is progressing and an answer to the “how is your pain or swelling?” or “how long did the last knee injection provide relief?” questions. We can also ask the global questions: Rate your status on a 1–10 scale, where 1 is best, 10 is worst.1 Medications can be reconciled, and appropriate refills placed.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The path forward in the new age of telemedicine evokes a new set of ethical concerns. Although presently necessary as a matter of safety for everyone, including patients, those who would accompany patients to outpatient clinic encounters, ourselves and our support staffs, it has not as yet been demonstrated that telemedicine is the clinical or ethical equivalent of face-to-face medical encounters. Neither has it been sufficiently demonstrated that it can be delivered with the same level of clinical competence as can face-to-face ambulatory care—competence being the first moral obligation of healthcare professionals.

Medical Professionalism

To suggest nothing will change in a new world of predominantly telemedicine is an assertion that currently cannot be supported. From the time a patient enters a physician’s office until their departure, important social dimensions to the encounter play out. These include greetings from familiar members of the staff and those who schedule follow-up visits and arrange for consultative referral, laboratory and imaging appointments. Patients have long-standing relationships with our support staffs and to diminish them with electronic, device-generated registration, referral and sign-out diminishes the therapeutic relationship.

The encounter itself, where decisions are made to continue current management or to make major changes in treatment plans, is different in telemedicine. Are such changes made confidently in remote encounters, and are patients and physicians confident making such decisions? During a telemedicine encounter, we can perform data entry and order studies, referrals and treatments, but the baseline uncertainty is fraught with new concerns generated by not being there.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The encounters of doctor and patient in telemedicine are transactional; the question remains whether they can be transformative and instrumental in enhancing human flourishing, one of the noble goals of medicine. The line between a telemedicine visit and a reassuring callback to a patient is blurry. If we now charge patients for the courtesy of a callback to provide results of completed studies, including the reassurance that results are normal or improved or to learn whether a newly prescribed treatment has helped, medical practice will resemble the billable-hours model of law practice. This is not to disparage law practice, but medicine has been different. This change risks commodifying the historic essence of medicine.

As we attempt to maintain the relational side of medicine, we must ask whether face-to-face visits will be limited to those needing some technical procedure. This seems an underutilization of the skills of some of the most humanistic physicians, such as those who provide primary care, allocating them to remote, electronic device-dominated modes of practice.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Ethics, Technology Tagged With: COVID-19, Speak Out Rheumatology, telemedicineIssue: October 2020

You Might Also Like:
  • With Apps & Remote Medicine, Japan Offers Glimpse of Doctor Visits in Post-COVID-19 Era
  • Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD
  • Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19
  • Some Telemedicine Barriers Are Down During COVID-19 Pandemic

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.